ArticleLeukemia2009
Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring.
M Zaliova et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papertrialcites it